Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99f16612ab84a8ad72da04fe99722e1f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29b2fa83a9560d4981e741f94d30b3e1 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-346 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-01021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1211 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0058 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0091 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17 |
filingDate |
2017-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69fad11c6b1c6606e9942e77dac0e4f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c9bff7aee6e627bd9fc4a47a8750c30 |
publicationDate |
2018-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2018027036-A1 |
titleOfInvention |
Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors |
abstract |
The present disclosure provides the use of fratricide-resistant chimeric antigen receptor T (CAR-T) cells targeting antigens expressed by T cell malignancies. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3784777-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021158783-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019226946-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10550183-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11440958-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10765699-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020095248-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022061115-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021062227-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019232409-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019232444-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018098306-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020095249-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112912493-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112867498-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018115906-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11648269-B2 |
priorityDate |
2016-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |